Post of duty: ​Headquarters – Washington, DC, United States. ​

The IDB Group is a community of diverse, versatile, and passionate people who come together on a journey to improve lives in Latin America and the Caribbean. Our people find purpose and do what they love in an inclusive, collaborative, agile, and rewarding environment.

About this position

The Social Protection and Health Division (SCL/SPof the IDB is seeking a consultant to conduct an analysis of the 2024 dengue epidemic in Brazil, with a focus on its impact on health system outcomes and health spending, as well as on strategies that

What you’ll do:

The activities that the selected candidate will perform include, but are not limited to, the following:

1. Review selected IDB publications (e.g., Going Beyond Normal: COVID19 and Healthcare in LAand other knowledge products (e.g., zika crowdsourcing initiativ.
2. Gather and analyze data on the 2024 dengue epidemic in Brazil, including infection rates and mortality rates (if available, by age, gender, race, and ethnicit. Compare the data across municipalities and states to identify areas that were more successful or less successful at managing the epidemic. Compare the 2024 data with previous years (if possible, with the 10 previous yearto assess any significant changes or trends due to the epidemic.
3. Analyze the distribution and prevalence of dengue virus serotypes (DENV1, DENV2, DENV3, and DENV4) in Brazil during the 2024 epidemic by reviewing epidemiological surveillance data. Collaborate with national institutions, such as the Ministry of Health and Fiocruz, to assess the relationship between serotypes and key variables like deaths, hospitalizations, and ambulatory visits. Where possible, extend the analysis to previous years for comparative purposes and consider geographic, socioeconomic, and demographic factors.
4. Evaluate the impact of the epidemic on the health system intermediate outcomes, such as hospital admissions, bed occupancy rates, and healthcare workforce strain. If possible, analyze the impact of the epidemic on the provision of routine health services (e.g., vaccinations, cancer screening, nonurgent treatment. The list of outcomes should be discussed and agreed upon with the IDB team. Compare the data across different states and municipalities. Compare the 2024 data with previous years (if possible, with the 10 previous yearto assess any significant changes or trends due to the epidemic.
5. Analyze the financial impact of the dengue epidemic on public and private health spending, including emergency response costs, treatment expenditures, preventative measures, and outofpocket spending (if availabl. Compare the data across different states and municipalities. Compare the 2024 spending with previous years (if possible, with the 10 previous yearto assess any significant changes or trends due to the epidemic.
6. Assess the broader economic impact of the dengue epidemic on society, particularly in terms of lost productivity due to illness, absenteeism from work or school, and longterm disability caused by severe cases. This analysis should consider both direct (e.g., days of work misseand indirect (e.g., economic consequences for households and employercosts. Where possible, compare these figures across different regions and demographic groups and evaluate trends in economic losses over time, particularly in relation to previous epidemics.
7. Conduct interviews and consultations with key stakeholders, including government health officials at the national level, from different states and municipalities, as well as and hospital managers, public health experts, and international organizations, to gather insights and perspectives on the epidemic response. Facilitate workshops or focus groups to discuss lessons learned and identify gaps in the current dengue response strategies (e.g., limited testing capacity, insufficient personne. Some of these sessions should focus on states and municipalities that were more and less successful in managing the epidemic, to explore variations in organization, resource allocation, costs, outputs, and outcomes, with the goal of identifying positive outliers whose performance can be studied and shared.
8. Review and document best practices in dengue management from Brazil and other comparable nations, as well as from different states and municipalities within Brazil. Analyze the effectiveness of interventions such as surveillance systems, vector control programs, public awareness campaigns, and vaccination efforts (if applicabl, by reviewing and analyzing existing systematic reviews. Describe the current state in the country and selected states and municipalities and identify critical gaps. Particular attention should be given to surveillance systems. Assess the differences in outcomes across states and municipalities, and identify key lessons learned from both successful and less successful experiences.
9. Develop actionable recommendations for improving the country’s preparedness and response to future dengue epidemics, including early warning systems and community engagement initiatives. Recommendations should be tailored to different contexts (e.g., urban vs. rural, wealthy vs. less wealthy states and municipalitie. To the extent possible, estimate the costs of key interventions, such as upgrading the existing surveillance system.
10. Prepare a comprehensive report summarizing the findings, analysis, and recommendations. Present the findings and recommendations to the Social Protection and Health Division (SCL/SPof the IDB and relevant country stakeholders.

​​